Srinivas Nalamachu | OMICS International
ISSN: 2167-0846

Journal of Pain & Relief
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Srinivas Nalamachu

President and Medical Director International Clinical Research Institute 8675 College Blvd, Suite 150 Overland Park, USA


Dr. Srinivas Nalamachu completed his medical education and mandatory internship from Kakatiya Medical College Teaching Hospitals, Warangal, India. He is currently president and medical director for the International Clinical Research Institute Inc. and co-director of the Pain Management Institute in Overland Park, Kansas. In addition, Dr. Nalamachu is clinical assistant professor, Department of Rehabilitation Medicine, Kansas University Medical Center, Kansas City, Kansas, and clinical assistant professor, Department of Internal Medicine, Kansas City University of Medicine and Biosciences, Kansas City, Missouri.

He is certified by the American Board of Physical Medicine and Rehabilitation, Dr. Nalamachu is a member of the American Academy of Pain Management, American Pain Society, American Association of Electrodiagnostic Medicine, and the International Association for Study of Pain. In addition, he is on the editorial board of Pain Clinician. His is the principal investigator in numerous studies involving breakthrough, chronic pain, low back pain, and neuropathic pain. Dr. Srinivas Nalamachu has received honoraria related to formal advisory activities from Allergan, Inc. and Cephalon, Inc., and honoraria related to speakers’ bureau activities from Elan Pharmaceuticals, Inc., Pharmacia Corporation (now Pfizer Inc.), Allergan, and Cephalon. He has also received grant support related to research activities from Allergan and Endo Pharmaceuticals.

Research Interest

Dr. Nalamachu got involved in clinical research to help patients and to help the advancement of science. In the last 10 years, he has participated as a Principal investigator in more than 70 clinical trials and has designed a number of them. He has authored more than 25 publications and more than 60 abstracts that were presented at various national and international pain and physical medicine societies. Since 2000, Dr. Nalamachuhas lectured more than 500 times at local, regional, national and international meetings. His research is focused onbotulinum toxins, cancer pain, neuropathic pain, and abuse-deterrent opiates.


Global Speakers in the subject

Global Experts in the subject